Isolation and characterization of two flavonoids, engeletin and astilbin, from the leaves of Engelhardia roxburghiana and their potential anti-inflammatory properties

Journal of Agricultural and Food Chemistry

Volumn 59, Issue 9, 2011, Pages 4562-4569

  Huang, Haiqiu ^a   Cheng, Zhihong ^a,b   Shi, Haiming ^c   Xin, Wenbo ^a   Wang, Thomas T Y ^d   Yu, Liangli ^a,c  

^a UNIVERSITY OF MARYLAND   (United States)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Anti inflammatory; Astilbin; Engeletin; Engelhardia roxburghiana

Indexed keywords

ANTI-INFLAMMATORIES; ANTI-INFLAMMATORY ACTIVITY; ANTI-INFLAMMATORY AGENTS; ASTILBIN; CHEMICAL STRUCTURE; CHEMOATTRACTANTS; CYCLOOXYGENASES; CYTOKINES; ENGELETIN; ENGELHARDIA ROXBURGHIANA; IMMUNE RESPONSE; INFLAMMATORY CYTOKINES; INHIBITORY EFFECT; INTERLEUKIN1; ISOLATION AND CHARACTERIZATION; LIPOPOLYSACCHARIDES; MACROPHAGE CELLS; MRNA EXPRESSION; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTORS;

DRUG PRODUCTS; GENE EXPRESSION; MACROPHAGES; MASS SPECTROMETRY; NUCLEIC ACIDS; RESONANCE;

NUCLEAR MAGNETIC RESONANCE;

ANTIINFLAMMATORY AGENT; ASTILBIN; ENGELETIN; FLAVONOL DERIVATIVE; GLYCOSIDE; INTERLEUKIN 1BETA; PLANT EXTRACT; TOLL LIKE RECEPTOR 4;

ANIMAL; ARTICLE; CHEMISTRY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; JUGLANDACEAE; MACROPHAGE; MOUSE; PLANT LEAF;

ANIMALS; ANTI-INFLAMMATORY AGENTS; FLAVONOLS; GENE EXPRESSION REGULATION; GLYCOSIDES; INTERLEUKIN-1BETA; JUGLANDACEAE; MACROPHAGES; MICE; PLANT EXTRACTS; PLANT LEAVES; TOLL-LIKE RECEPTOR 4;

ENGELHARDIA ROXBURGHIANA;

EID: 79955691865     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf2002969     Document Type: Article

References (49)

1. Haraguchi, H.; Mochida, Y.; Sakai, S.; Masuda, H.; Tamura, Y.; Mizutani, K.; Tanaka, O.; Chou, W. H. Protection against oxidative damage by dihydroflavonols in Engelhardtia chrysolepis. Biosci., Biotechnol., Biochem. 1996, 60, 945-948. (Pubitemid 26311230)
2. Haraguchi, H.; Ohmi, I.; Fukuda, A.; Tamura, Y.; Mizutani, K.; Tanaka, O.; Chou, W. H. Inhibition of aldose reductase and sorbitol accumulation by astilbin and taxifolin dihydroflavonols in Engelhardtia chrysolepis. Biosci., Biotechnol., Biochem. 1997, 61, 651-654. (Pubitemid 27315386)
3. Igarashi, K.; Uchida, Y.; Murakami, N.; Mizutani, K.; Masuda, H. Effect of astilbin in tea processed from leaves of Engelhardtia chrysolepis on the serum and liver lipid concentrations and on the erythrocyte and liver antioxidative enzyme activities of rats. Biosci., Biotechnol., Biochem. 1996, 60, 513-515. (Pubitemid 126460942)
4. Motoyashiki, T.; Miyake, M.; Morita, T.; Mizutani, K.; Masuda, H.; Ueki, H. Enhancement of the vanadate-simulated release of lipoprotein lipase activity by astilbin from the leaves of Engelhardtia chrysolepis. Biol. Pharm. Bull. 1998, 21, 517-519. (Pubitemid 28259426)
5. Kasai, R.; Hirono, S.; Chou, W. H.; Tanaka, O.; Chen, F. H. Sweet dihydroflavonol rhamnoside from leaves of Engelhardtia chrysolepis, a Chinese folk medicine, Hung-qi. Chem. Pharm. Bull. 1988, 36, 4167-4170. (Pubitemid 18266858)
6. Zhou, H. P.; Lutterodt, H.; Cheng, Z. H.; Yu, L. L. Anti-inflammatory and antiproliferative activities of trifolirhizin, a flavonoid from Sophora flavescens roots. J. Agric. Food Chem. 2009, 57, 4580-4585.
7. Kim, D. W.; Chi, Y. S.; Son, K. H.; Chang, H. W.; Kim, J. S.; Kang, S. S.; Kim, H. P. Effects of sophoraflavanone G, a prenylated flavonoid from Sophora flavescenes, on cyclooxygenase-2 and in vitro inflammatory response. Arch. Pharm. Res. 2002, 25, 329-335. (Pubitemid 43093314)
8. Trousdale, E. K.; Singleton, V. L. Astilbin and engeletin in grapes and wine. Phytochemistry 1983, 22, 619-620.
9. Monagas, M.; Bartolomé, B.; Gómez-Cordovés, C. Updated knowledge about the presence of phenolic compounds in wine. Crit. Rev. Food Sci. Nutr. 2005, 45, 85-118. (Pubitemid 41657358)
10. Wirasathien, L.; Pengsuparp, T.; Suttisri, R.; Ueda, H.; Moriyasu, M.; Kawanishi, K. Inhibitors of aldose reductase and advanced glycation end-products formation from the leaves of Stelechocarpus cauliflorus R. E. Fr. Phytomedicine 2007, 14, 546-550. (Pubitemid 47068942)
11. Aggarwal, B. B. Nuclear factor-κB: The enemy within. Cancer Cell 2004, 6, 203-208.
12. Wyss-Coray, T. Inflammation in Alzheimer disease: Driving force, bystander or beneficial response? Nat. Med. 2006, 12, 1005-1015. (Pubitemid 44353380)
13. Reuter, S.; Gupta, S. C.; Chaturvedi, M. M.; Aggarwal, B. B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radical Biol. Med. 2010, 49, 1603-1616.
14. Deakin, A. M.; Payne, A. N.; Whittle, B. J. R.; Moncada, S. The modulation of IL-6 and TNF-α release by nitric oxide following stimulation of J774 cells with LPS and IFN-γ. Cytokine 1995, 7, 408-416.
15. Trasino, S. E.; Kim, Y. S.; Wang, T. T. Y. Ligand, receptor, and cell type-dependent regulation of ABCA1 and ABCG1 mRNA in prostate cancer epithelial cells. Mol. Cancer Ther. 2009, 8, 1934-1945.
16. Wang, T. T. Y.; Hudson, T. S.; Wang, T. C.; Remsberg, C. M.; Davies, N. M.; Takahashi, Y.; Kim, Y. S.; Seifried, H.; Vinyard, B. T.; Perkins, S. N.; Hursting, S. D. Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 2008, 29, 2001-2010.
17. Takahashi, Y.; Perkins, S. N.; Hursting, S. D.; Wang, T. T. Y. 17β-Estradiol differentially regulates androgen-responsive genes through estrogen receptor-β- and extracellular-signal regulated kinasedependent pathways in LNCaP human prostate cancer cells. Mol. Carcinog. 2007, 46, 117-129.
18. Baderschneider, B.; Winterhalter, P. Isolation and characterization of novel benzoates, cinnamates, flavonoids, and lignans from Riesling wine and screening for antioxidant activity. J. Agric. Food Chem. 2001, 49, 2788-2798. (Pubitemid 32826069)
19. Silva, D. H. S.; Yoshida, M.; Kato, M. J. Flavonoids from Iryanthera sagotiana. Phytochemistry 1997, 46, 579-582. (Pubitemid 27414946)
20. Gangloff, M.; Weber, A. N. R.; Gibbard, R. J.; Gay, N. J. Evolutionary relationships, but functional differences, between the Drosophila and human toll-like receptor families. Biochem. Soc. Trans. 2003, 31, 659-663. (Pubitemid 36750751)
21. Buchanan, M. M.; Hutchinson, M.; Watkins, L. R.; Yin, H. Tolllike receptor 4 in CNS pathologies. J. Neurochem. 2010, 114, 13-27.
22. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity. Cell 2006, 124, 783-801. (Pubitemid 43261452)
23. Cuschieri, J.; Billigren, J.; Maier, R. V. Endotoxin tolerance attenuates LPS-induced TLR4 mobilization to lipid rafts: A condition reversed by PKC activation. J. Leukocyte Biol. 2006, 80, 1289-1297. (Pubitemid 44911046)
24. Murao, L. E.; Shisler, J. L. The MCV MC159 protein inhibits late, but not early, events of TNF-α-induced NF-κB activation. Virology 2005, 340, 255-264. (Pubitemid 41317499)
25. Wang, P. L.; Meinhardt, B.; Andre, R.; Renshaw, B. R.; Kimber, I.; Rothwell, N. J.; Pinteaux, E. The interleukin-1-related cytokine IL-1F8 is expressed in glial cells, but fails to induce IL-1β signaling responses. Cytokine 2005, 29, 245-250. (Pubitemid 40320924)
26. Cao, J.; Jiang, L. P.; Zhang, X. M.; Yao, X. F.; Geng, C. Y.; Xue, X. X; Zhong, L. F. Boric acid inhibits LPS-induced TNF-α formation through a thiol-dependent mechanism in THP-1 cells. J. Trace Elem. Med. Biol. 2008, 22, 189-195.
27. Silswal, N.; Singh, A. K.; Aruna, B.; Mukhopadhyay, S.; Ghosh, S.; Ehtesham, N. Z. Human resistion stimulates the pro-inflamatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway. Biochem. Biophys. Res. Commun. 2005, 334, 1092-1101. (Pubitemid 41074686)
28. Li, Y. Y.; Hsieh, L. L.; Tang, R. P.; Liao, S. K.; Yeh, K. Y. Interleukin-6 (IL-6) released by macrophages induces IL-6 secretion in the human colon cancer HT-29 cell line. Hum. Immunol. 2009, 70, 151-158.
29. Heikkilä, K.; Ebrahim, S.; Lawlor, D. A. Systematic review of the association between circulating interleukin-6 (IL-6) and cancer. Eur. J. Cancer 2008, 44, 937-945.
30. Pietrzak, A.; Misiak-Tzoczek, A.; Brzezińska-Baszczyk, E. Interleukin (IL)-10 inhibits RANTES-, tumour necrosis factor (TNF)- and nerve growth factor (NGF)-induced mast cell migratory response but is not a mast cell chemoattractant. Immunol. Lett. 2009, 123, 46-51.
31. Ye, Z.; Huang, H.; Hao, S.; Xu, S.; Yu, H.; Hurk, S.; Xiang, J. IL-10 has a distinct immunoregulatory effect on naive and active T cell subsets. J. Interferon Cytokine Res. 2007, 27, 1031-1038.
32. Mocellin, S.; Marincola, F.; Rossi, C. R.; Nitti, D.; Lise, M. The multifaceted relationship between IL-10 and adaptive immunity: Putting together the pieces of a puzzle. Cytokine Growth Factor Rev. 2004, 15, 61-76. (Pubitemid 38121291)
33. Vora, M.; Romero, L. I.; Kasasek, M. A. Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells. J. Exp. Med. 1996, 184, 821-829. (Pubitemid 26313540)
34. Mocellin, S.; Panelli, M. C.; Wang, E.; Nagorsen, D.; Marincola, F. M. The dual role of IL-10. Trends Immunol. 2003, 24, 36-43. (Pubitemid 35462111)
35. Shibata, Y.; Foster, L. A.; Kurimoto,M.; Okamura, H.; Nakamura, R. M.; Kawajiri, K.; Justice, J. P.; Van Scott, M. R.; Myrvik, Q. N.; Metzger, W. J. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-γ-inducing factors but enhances NK cell production of IFN-γ. J. Immunol. 1998, 161, 4283-4288. (Pubitemid 28469012)
36. Steube, K. G.; Meyer, C.; Drexler, H. G. Constitutive protein expression of monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and regulation of the secretion by anti- and proinflammatory stimuli. Leuk. Res. 1999, 23, 843-849. (Pubitemid 29341475)
37. Gu, L.; Okada, Y.; Clinton, S. K.; Gerard, C.; Sukhova, G. K.; Libby, P.; Rollins, B. J. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 1998, 2, 275-281. (Pubitemid 128373654)
38. Nemeth, Z. H.; Deitch, E. A.; Lu, Q.; Szabo, C.; Hasko, G. NHE blockade inhibits chemokine production and NF-κB activation in immunostimulated endothelial cells. Am. J. Physiol. 2002, 283, C396-C403. (Pubitemid 34787521)
39. Smith, W. L.; Langenbach, R. Why there are two cyclooxygenase isozymes. J. Clin. Invest. 2001, 107, 1491-1495. (Pubitemid 32574631)
40. Ghosh, N.; Chaki, R.; Mandal, V.; Mandal, S. C. COX-2 as a target for cancer chemotherapy. Pharmacol. Rep. 2010, 62, 233-244.
41. Saldivar, J. S.; Lopez, D.; Feldman, R. A.; Tharappel-Jacob, R.; de la Rosa, A.; Terreros, D.; Baldwin, W. S. COX-2 overexpression as a biomarker of early cervical carcinogenesis: A pilot study. Gynecol. Oncol. 2007, 107, S155-S162. (Pubitemid 47483864)
42. Khan, A. A.; Iadarola, M.; Yang, H. Y. T.; Dionne, R. A. Expression of COX-1 and COX-2 in a clinical model of acute inflammation. J. Pain 2007, 8, 349-354. (Pubitemid 46551877)
43. Macarthur, M.; Hold, G. L.; El-Omar, E. M. Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. 2004, 286, G515-G520. (Pubitemid 38374969)
44. Coussens, L. M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867. (Pubitemid 36019639)
45. Mantovani, A. Inflammation by remote control. Nature 2005, 435, 752-753.
46. Aggarwal, B. B.; Shishodia, S.; Sandur, S. K.; Pandey, M. K.; Sethi, G. Inflammation and cancer: How hot is the link? Biochem. Pharmacol. 2006, 72, 1605-1621. (Pubitemid 44666739)
47. 1 and IL-6 induced by LPS in human PC3 cells via TLR4-NF-κB signaling blockage. Int. Immunopharmacol. 2010, 10, 50-56.
48. Nair, H. K.; Rao, K. V. K.; Aalinkeel, R.; Mahajan, S.; Chawda, R.; Schwartz, S. A. Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin. Diagn. Lab. Immunol. 2004, 11, 63-69. (Pubitemid 38090653)
49. Fang, J.; Zhou, Q.; Shi, X. L.; Jiang, B. H. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells. Carcinogenesis 2007, 28, 713-723. (Pubitemid 46523369)